Original news and analysis on international IP policy
According to sources, countries have agreed in the nick of time on a draft resolution on cancer prevention, control, and access to cancer medicines, and in particular the price of new cancer medicines, to be examined at the World Health Assembly next week.
The World Intellectual Property Organization, as a United Nations specialised agency, has a role to play in the implementation of the UN Sustainable Development Goals (SDGs) for the year 2030. How that might happen, and which goals the organisation should pursue are a matter of ongoing discussion at the WIPO Committee on Development and Intellectual Property this week. Views diverge on whether the 17 SDGs should be considered as a whole, of if the organisation should focus on what is considered as its particular expertise and mission.
Pharmaceutical industry representatives today announced a new alliance to fight antimicrobial resistance. The announcement came during a meeting of the private sector of the most advanced countries.
The African Union delegation to the United Nations came in outspoken numbers to a press briefing today to express unshakable support for the Ethiopian candidate to be the next head of the World Health Organization, Tedros Adhanom Ghebreyesus.
The new head of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has hit the ground running in Geneva, and is weighing in on a variety of policy issues, this week providing a list of priorities for the research-based pharma industry at the upcoming annual World Health Assembly.
There are many who see the World Health Organization mechanism to prepare and face the next influenza pandemic and insure availability of treatments as a success. However, some questions remain.
In a few days, the 70th World Health Assembly will open its doors in Geneva with a marathon agenda, and over 4,000 registered delegates. The election of a new director general, the approval of the budget for the next biennium (2018/2019) are set to capture the attention of member states. However, many other subjects require their consideration, such as a resolution on cancer treatment costs, research and development for epidemic diseases, for new antibiotics, for medicines affecting primarily poor populations, access to medicines, and the influenza pandemic preparedness framework.
A five-year partnership between the Office of the United Nations High Commissioner for Human Rights (OHCHR) and Microsoft was announced today.
The 70th World Health Assembly opening in a few days is the WHA of superlatives, according to a World Health Organization’s official. It is the longest assembly ever, with nine days of meeting, the largest number delegates, of agenda items, and of documents. It is also when the new WHO new director general will be elected, and when the WHO next budget is expected to be approved.
The World Health Organization has concluded a major one-day forum on fair pricing of medicines, bringing a wide range of stakeholders together in Amsterdam and coming up with several possible actions for the way ahead. Key points of discussion included a definition of fair pricing, moving away from value-based pricing, delinkage of price from research and development costs, and greater transparency, according to participants.